It is currently Wed May 04, 2016 11:59 pm

News News of General Discussion

Site map of General Discussion » Forum : General Discussion

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Undiagnosed Symptoms

I am a 31 year old female. About 4 months ago I started getting pain in my back. This lasted quite a few weeks and during this time I went to the doctor a few times and a physiotherapist. I began to feel nerve pain down my arms. This feeling would come and go and at first the physiotherapist thought it could be related to my back injury. The pain in my back eventually went ...
Read more : Undiagnosed Symptoms | Views : 181 | Replies : 2


Random pain coming and going

Diagnosed 3 years ago, although MS was probably present and "latent" for 25+ years. Now, I am getting unexplained muscle pain. First, my lower back had excruciating pain unexplained by any activity or incident. Mobic did not help. After apx. 3 weeks, it went away. Next, my shoulder started paining me greatly, with no apparent source of trauma or injury. The pain goes all the way up my neck to behind my ear, then into ...
Read more : Random pain coming and going | Views : 246 | Replies : 1


Muscle spasms help

Hi everyone,

New here. I am seeking help for ideas of what to do about muscle spasms. I have them all over, and they are very painful. My muscles seize up completely, and also ache with muscle pain that worsens in the evening/night. I am wondering if anyone knows of natural remedies, or ways to help with this?

Thank you so much!

Lisa
Read more : Muscle spasms help | Views : 326 | Replies : 5


Test identifies young MS patients at increased risk...

Test identifies young MS patients at increased risk of impaired cognition

A test that measures olfactory dysfunction is an easy method of identifying patients with paediatric-onset multiple sclerosis (POMS) who are at increased risk of cognitive impairment, according to a study presented at the 68th Annual Meeting of the American Academy of Neurology (AAN)...Read more - http://www.ms-uk.org/MSnews
Read more : Test identifies young MS patients at increased risk... | Views : 242 | Replies : 0


DNA tests on two million to revolutionise 'smart drug'.....

DNA tests on two million to revolutionise 'smart drug' treatments for diseases

Scientists are set to revolutionise medicine by sampling the DNA of two million people to develop new drugs, the Daily Mail reports...Read more - http://www.ms-uk.org/MSnews
Read more : DNA tests on two million to revolutionise 'smart drug'..... | Views : 222 | Replies : 0


Link between MS disease activity & food allergies discussed

New data demonstrates increased disease activity in patients with multiple sclerosis (MS) and a history of food allergies, according to a study presented at the 68th Annual Meeting of the American Academy of Neurology (AAN)...Read more - http://www.ms-uk.org/MSnews
Read more : Link between MS disease activity & food allergies discussed | Views : 231 | Replies : 0


Stopping smoking slows brain volume loss

Stopping smoking could help to slow brain volume loss in patients with multiple sclerosis (MS), according to data presented at the 2016 annual meeting of the American Academy of Neurology (AAN)...Read more - http://www.ms-uk.org/MSnews
Read more : Stopping smoking slows brain volume loss | Views : 215 | Replies : 0


‘No evidence of disease activity’ for Ocrelizab patients

‘No evidence of disease activity’ for multiple sclerosis patients on Ocrelizumab

Patients with multiple sclerosis (MS) taking Ocrelizumab are more likely to achieve no evidence of disease activity (NEDA) than those taking beta interferon, researchers from the pivotal OPERA I and OPERA II phase III trials have reported...Read more - http://www.ms-uk.org/MSnews
Read more : ‘No evidence of disease activity’ for Ocrelizab patients | Views : 250 | Replies : 1


DMF ‘significantly reduces disability progression’

Delayed-release dimethyl fumarate (DMF) has been associated with significant reductions in confirmed disability progression (CDP) in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS), compared with placebo, presented J. Theodore Phillips, MD, PhD, FAAN, Baylor Institute for Immunology Research, Dallas, TX, at the 68th American Academy of Neurology meeting in Vancouver, Canada...Read more - http://www.ms-uk.org/MSnews
Read more : DMF ‘significantly reduces disability progression’ | Views : 306 | Replies : 0


Daclizumab HYP improves cognition - report

Patients with relapsing-remitting multiple sclerosis (MS) treated with daclizumab high-yield process (HYP) had improved cognitive outcomes at 96 weeks compared with beta interferon, a study presented at the 68th American Academy of Neurology meeting has found...Read more - http://www.ms-uk.org/MSnews
Read more : Daclizumab HYP improves cognition - report | Views : 238 | Replies : 0


 

Login  •  Register


Statistics

Total posts 232106 • Total topics 24795 • Total members 15959


Contact us | Terms of Service